A Hypothesis-Directed Approach to the Targeted Development of a Multiplexed Proteomic Biomarker Assay for Cancer
In recent years, hundreds of candidate protein biomarkers have been identified using discovery-based proteomics. Despite the large number of candidate biomarkers, few proteins advance to clinical validation. We propose a hypothesis-driven approach to identify candidate biomarkers, previously charact...
Main Authors: | Emily M. Mackay, Jennifer Koppel, Pooja Das, Joanna Woo, David C. Schriemer, Oliver F. Bathe |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2015-01-01
|
Series: | Cancer Informatics |
Online Access: | https://doi.org/10.4137/CIN.S24388 |
Similar Items
-
A Hypothesis-Directed Approach to the Targeted Development of a Multiplexed Proteomic Biomarker Assay for Cancer
by: Emily M. Mackay, et al.
Published: (2015-05-01) -
Aptamer-based multiplexed proteomic technology for biomarker discovery.
by: Larry Gold, et al.
Published: (2010-12-01) -
From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assay.
by: Stephan Kraemer, et al.
Published: (2011-01-01) -
Optimization of the multiplexed Proximity Ligation Assay for detection of blood-based biomarkers
by: Lundberg, Martin
Published: (2014) -
54 Patient stratification using clinical proteomics – validated multiplexed MRM assays to quantify HER2 and other biomarkers in clinical FFPE tissues
by: Michael Schirm, et al.
Published: (2020-11-01)